Evaluation of the Magnesium sulfate effect in ischemic stroke treatment
Phase 2
- Conditions
- ischemic stroke.Stroke
- Registration Number
- IRCT138901101856N2
- Lead Sponsor
- Vice-chancellor for research, Kermanshah University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 97
Inclusion Criteria
patient’s age between 40-95 years,last known well time within 12 hoursof treatment initiation . Exclusion criteria:pregnancy-coma -heart block-chronic renal impairment- respiratory distress(24 < RR < 12 ?? o2sat < 90)- systolic blood pressure <90 or >220mmhg- pre-existing neuralgic psychiatric or advanced systemic disease that confound neuralgical or functional outcome evaluation -hemorrhagic stroke - known recent stroke wheithin past 30 days- rapidly resolving deficit
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measure of global disability. Timepoint: before of the treatment ,3days after treatment and discharge time. Method of measurement: according to modified Rankin scale.;Mortality rate. Timepoint: During admition times. Method of measurement: patient' s medical documents.;Amount of admition times. Timepoint: discharge time. Method of measurement: patient' s medical documents.
- Secondary Outcome Measures
Name Time Method Clinical side effects. Timepoint: daily. Method of measurement: According to patients daily notes.